TOP HEADLINES

Editor's Corner

French scientists roll out rapid diagnostic test for Ebola

As concern mounts over the deadly Ebola epidemic, French scientists are developing a diagnostic tool that works similar to a home pregnancy test and can quickly identify the virus through a tiny fluid sample.

InSilixa ropes in $13M from PointGuard Ventures and Morningside for molecular Dx tests

Silicon Valley startup InSilixa roped in $13M in financing to develop its innovative molecular diagnostic tests for drug-resistant bacteria and infections.

Cleveland Clinic crew identifies possible lung cancer biomarkers

Cleveland Clinic scientists believe they have identified possible blood biomarkers that could help detect lung cancer, based on the alteration of metabolic processes that happens to patients with the disease at various stages.

BioMérieux subsidiary nails Medicare coverage for breast cancer molecular test

A subsidiary of French in vitro diagnostics giant bioMérieux gained Medicare coverage for a new breast cancer test, a vital milestone necessary to compete in today's market.

Celgene takes equity stake in Sequenta and its precise Dx tech

Sequenta attracted new equity investment from Celgene and other unnamed parties that back the use of its technology in the drug development process and the creation of new ultraprecise diagnostic tests.

MORE NEWS

From Our Sister Sites

FierceCRO

WuXi PharmaTech has struck a deal with the genomics experts at Foundation Medicine, signing on to offer the company's cancer-decoding services to drug developers in its native China.

FiercePharma Manufacturing

Denmark-based Novo Nordisk said on Friday that it had received a subpoena from a U.S. Attorney who wants some info about its manufacturing operations at a plant in Kalundborg. But the company said it really has no idea why.